Phase II study of bendamustine combined with rituximab in relapsed/refractory mantle cell lymphoma: efficacy, tolerability, and safety findings
Crossref DOI link: https://doi.org/10.1007/s00277-015-2478-9
Published Online: 2015-09-28
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Czuczman, Myron S.
Goy, A.
Lamonica, D.
Graf, D. A.
Munteanu, M. C.
van der Jagt, R. H.
Text and Data Mining valid from 2015-09-28